| J9271 | Injection, pembrolizumab, 1 mg | 5,000 | $40 | $215K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 780 | $100 | $81.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 53,250 | $1 | $53.3K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 120 | $350 | $40.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 230 | $120 | $26.9K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 290 | $70 | $19.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 270 | $70 | $19.1K |
| J0897 | Injection, denosumab, 1 mg | 840 | $20 | $15.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 170 | $60 | $10.1K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 350 | $30 | $9.2K |